Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer

-
Investigator: Michelle E. Melisko, MD
Sponsor: Genentech, Inc.

Location(s): United States

Description

This multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxe l with placebo in patients with locally recurrent or metastatic breast cancer.